Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
Neuropsychiatric Disease and Treatment
|
February 11, 2014
A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder
Gang Wang, Alexander McIntyre, Willie R Earley, et al.
Plos One
|
January 2, 2025
The Scania Accelerated Intermittent Theta-burst Implementation Study (SATIS)-Lessons from an accelerated treatment protocol
Marcus Persson, Viktor Fabri, Alexander Reijbrandt, et al.
Journal of Interprofessional Care
|
August 11, 2021
Team-based visits within Swedish child healthcare services: a national cross-sectional study
Ulrika Svea Nygren, Ylva Tindberg, Leif Eriksson, et al.
Journal of Comparative Effectiveness Research
|
October 3, 2014
Impact of extended-release quetiapine fumarate on hospitalization length and cost in schizophrenia and bipolar disorder patients: a retrospective, hospital-based, US-cohort analysis
Julie C Locklear, Peter Wahlqvist, Urban Gustafsson, et al.
Human Psychopharmacology
|
December 7, 2011
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies
Dan J Stein, Borwin Bandelow, Charles Merideth, et al.
Depression and Anxiety
|
August 25, 2010
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial
Michael Liebowitz, Raymond W Lam, Ulla Lepola, et al.
Journal of Clinical Psychopharmacology
|
December 17, 2014
Safety and tolerability of dexmecamylamine (TC-5214) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to antidepressant therapy: results of a long-term study
Raj Tummala, Dhaval Desai, Johan Szamosi, et al.
Depression and Anxiety
|
July 4, 2012
Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression
Michael E Thase, Koen Demyttenaere, Willie R Earley, et al.
International Clinical Psychopharmacology
|
October 29, 2013
Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels
Stuart A Montgomery, A Carlo Altamura, Heikki Katila, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
April 10, 2013
Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder
Heikki Katila, Irina Mezhebovsky, Amy Mulroy, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
Neuropsychiatric Disease and Treatment
|
February 11, 2014
A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder
Gang Wang, Alexander McIntyre, Willie R Earley, et al.
Plos One
|
January 2, 2025
The Scania Accelerated Intermittent Theta-burst Implementation Study (SATIS)-Lessons from an accelerated treatment protocol
Marcus Persson, Viktor Fabri, Alexander Reijbrandt, et al.
Journal of Interprofessional Care
|
August 11, 2021
Team-based visits within Swedish child healthcare services: a national cross-sectional study
Ulrika Svea Nygren, Ylva Tindberg, Leif Eriksson, et al.
Journal of Comparative Effectiveness Research
|
October 3, 2014
Impact of extended-release quetiapine fumarate on hospitalization length and cost in schizophrenia and bipolar disorder patients: a retrospective, hospital-based, US-cohort analysis
Julie C Locklear, Peter Wahlqvist, Urban Gustafsson, et al.
Human Psychopharmacology
|
December 7, 2011
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies
Dan J Stein, Borwin Bandelow, Charles Merideth, et al.
Depression and Anxiety
|
August 25, 2010
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial
Michael Liebowitz, Raymond W Lam, Ulla Lepola, et al.
Journal of Clinical Psychopharmacology
|
December 17, 2014
Safety and tolerability of dexmecamylamine (TC-5214) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to antidepressant therapy: results of a long-term study
Raj Tummala, Dhaval Desai, Johan Szamosi, et al.
Depression and Anxiety
|
July 4, 2012
Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression
Michael E Thase, Koen Demyttenaere, Willie R Earley, et al.
International Clinical Psychopharmacology
|
October 29, 2013
Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels
Stuart A Montgomery, A Carlo Altamura, Heikki Katila, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
April 10, 2013
Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder
Heikki Katila, Irina Mezhebovsky, Amy Mulroy, et al.
Page
of 6